173 related articles for article (PubMed ID: 11367532)
1. Cell-specific regulation of the CD21 gene.
Zabel MD; Weis JH
Int Immunopharmacol; 2001 Mar; 1(3):483-93. PubMed ID: 11367532
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements.
Zabel MD; Byrne BL; Weis JJ; Weis JH
J Immunol; 2000 Oct; 165(8):4437-45. PubMed ID: 11035082
[TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.
Zabel MD; Wheeler W; Weis JJ; Weis JH
J Immunol; 2002 Apr; 168(7):3341-50. PubMed ID: 11907091
[TBL] [Abstract][Full Text] [Related]
4. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
[TBL] [Abstract][Full Text] [Related]
5. Expression of the murine CD21 gene is regulated by promoter and intronic sequences.
Hu H; Martin BK; Weis JJ; Weis JH
J Immunol; 1997 May; 158(10):4758-68. PubMed ID: 9144490
[TBL] [Abstract][Full Text] [Related]
6. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.
Braun M; Melchers I; Peter HH; Illges H
Int Immunol; 1998 Aug; 10(8):1197-202. PubMed ID: 9723706
[TBL] [Abstract][Full Text] [Related]
7. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
8. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes.
Debnath I; Roundy KM; Weis JJ; Weis JH
J Immunol; 2007 Jun; 178(11):7139-50. PubMed ID: 17513763
[TBL] [Abstract][Full Text] [Related]
9. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
10. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis.
Del Nagro CJ; Kolla RV; Rickert RC
J Immunol; 2005 Oct; 175(8):5379-89. PubMed ID: 16210644
[TBL] [Abstract][Full Text] [Related]
11. Regulation of humoral immune responses by CD21/CD35.
Chen Z; Koralov SB; Kelsoe G
Immunol Rev; 2000 Aug; 176():194-204. PubMed ID: 11043778
[TBL] [Abstract][Full Text] [Related]
12. Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells.
Taylor RL; Cruickshank MN; Karimi M; Ng HL; Quail E; Kaufman KM; Harley JB; Abraham LJ; Tsao BP; Boackle SA; Ulgiati D
Cell Mol Immunol; 2016 Jan; 13(1):119-31. PubMed ID: 25640655
[TBL] [Abstract][Full Text] [Related]
13. Analysis of tandem E-box motifs within human Complement receptor 2 (CR2/CD21) promoter reveals cell specific roles for RP58, E2A, USF and localized chromatin accessibility.
Cruickshank MN; Dods J; Taylor RL; Karimi M; Fenwick EJ; Quail EA; Rea AJ; Holers VM; Abraham LJ; Ulgiati D
Int J Biochem Cell Biol; 2015 Jul; 64():107-19. PubMed ID: 25817480
[TBL] [Abstract][Full Text] [Related]
14. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
15. CD19 can regulate B lymphocyte signal transduction independent of complement activation.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Tedder TF
J Immunol; 2001 Sep; 167(6):3190-200. PubMed ID: 11544305
[TBL] [Abstract][Full Text] [Related]
16. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
17. Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2.
Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2009 Dec; 47(2-3):517-25. PubMed ID: 19740539
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD21 expression by DNA methylation and histone deacetylation.
Schwab J; Illges H
Int Immunol; 2001 May; 13(5):705-10. PubMed ID: 11312258
[TBL] [Abstract][Full Text] [Related]
19. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice.
Pozdnyakova O; Guttormsen HK; Lalani FN; Carroll MC; Kasper DL
J Immunol; 2003 Jan; 170(1):84-90. PubMed ID: 12496386
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.
Illges H; Braun M; Peter HH; Melchers I
Clin Exp Immunol; 2000 Nov; 122(2):270-6. PubMed ID: 11091285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
